Sign In

Henry Skinner

Henry Skinner is a highly experienced professional with an extensive background in the field of biotechnology, microbiology, and genetics.

He holds a Doctor of Philosophy in Microbiology from the University of Illinois at Urbana-Champaign, a degree in Genetics from Baylor College of Medicine, and a Bachelor of Science in Biotechnology, Biology from Worcester Polytechnic Institute.

Henry Skinner also pursued studies in health care and law at Texas A&M University and received his secondary education at Portsmouth Abbey School.

His professional journey includes notable roles such as being the Chief Executive Officer at Amr Action Fund and holding senior positions at prestigious organizations like Tekla Capital Management and Novartis.

His past experiences encompass leadership positions at Novartis Ventures, Novartis Institutes for Biomedical Research, Selectx Pharmaceuticals, and Neogenesis Pharmaceuticals, among others.

Henry Skinner's career spans various facets of the pharmaceutical and biotechnology industries, including strategic alliances, venture funding, business development, and technology acquisitions.

With a solid educational foundation and a wealth of experience in executive management, Henry Skinner continues to be a prominent figure in the realm of healthcare and biotechnology.

Highlights

Jun 3 · linkedin

The flight of talent from antimicrobial R&D and clinical practice is a deeply troubling trend that could affect everything from how antibiotics are discovered, prescribed, and dispensed, to regulators' ability to evaluate antibiotic candidates in the future. I appreciate STAT for letting me share my concerns on this overlooked issue, and I’m grateful for all of the AMR researchers and ID clinicians and pharmacists who continue pushing good science and medicine forward in this challenging environment: https://lnkd.in/exa557FJ

Henry Skinner
Add to my network

Location

Greater Boston Area